human phospho kinase dot blot array (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
98
Structured Review
R&D Systems
human phospho kinase dot blot array
Human Phospho Kinase Dot Blot Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 941 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+phospho+kinase+dot+blot+array/Proteome+Profiler+Human+Phospho-Kinase+Array+Kit/pm37269887-71-20-26
Average 98 stars, based on 941 article reviews
Human Phospho Kinase Dot Blot Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 941 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+phospho+kinase+dot+blot+array/Proteome+Profiler+Human+Phospho-Kinase+Array+Kit/pm37269887-71-20-26
Average 98 stars, based on 941 article reviews
human phospho kinase dot blot array - by Bioz Stars,
2026-09
98/100 stars
Images
Related Articles
Dot Blot:Article Title: ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation Article Snippet: .. A Article Title: Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells. Article Snippet: Neratinib (NE) is an irreversible pan-ERBB tyrosine kinase inhibitor used to treat breast cancers (BCa) with amplification of the ERBB2/HER2/Neu gene or overexpression of the ERBB2 receptor.. However, the mechanisms behind this process are not fully understood.. Here we investigated the effects of NE on critical cell survival processes in ERBB2 cancer cells. Article Title: Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling Article Snippet: .. TNBC cells were treated with fisetin and quercetin at a 200 μM concentration for 6 h. A Phospho-proteomics:Article Title: ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation Article Snippet: .. A Article Title: Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells. Article Snippet: Neratinib (NE) is an irreversible pan-ERBB tyrosine kinase inhibitor used to treat breast cancers (BCa) with amplification of the ERBB2/HER2/Neu gene or overexpression of the ERBB2 receptor.. However, the mechanisms behind this process are not fully understood.. Here we investigated the effects of NE on critical cell survival processes in ERBB2 cancer cells. Article Title: Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling Article Snippet: .. TNBC cells were treated with fisetin and quercetin at a 200 μM concentration for 6 h. A Concentration Assay:Article Title: Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling Article Snippet: .. TNBC cells were treated with fisetin and quercetin at a 200 μM concentration for 6 h. A |